These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 36605077)

  • 1. N6-methyladenosine (m6A) RNA modification in the pathophysiology of heart failure: a narrative review.
    Liu S; Wang T; Cheng Z; Liu J
    Cardiovasc Diagn Ther; 2022 Dec; 12(6):908-925. PubMed ID: 36605077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regulatory mechanisms of N6-methyladenosine modification in ferroptosis and its implications in disease pathogenesis.
    Tao X; Kang N; Zheng Z; Zhu Z; Ma J; He W
    Life Sci; 2024 Oct; 355():123011. PubMed ID: 39181316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification.
    Kumari R; Ranjan P; Suleiman ZG; Goswami SK; Li J; Prasad R; Verma SK
    Cardiovasc Res; 2022 Jun; 118(7):1680-1692. PubMed ID: 33956076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N6-Methyladenosine Modification Participates in the Progression of Hepatitis B Virus-Related Liver Fibrosis by Regulating Immune Cell Infiltration.
    Zhao T; Qi J; Liu T; Wu H; Zhu Q
    Front Med (Lausanne); 2022; 9():821710. PubMed ID: 35308519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Roles and Mechanism of m6A Methylation in Cardiometabolic Diseases.
    Xu Z; Lv B; Qin Y; Zhang B
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic role of N6-methyladenosine (m6A) RNA methylation in the cardiovascular system.
    Zhao K; Yang CX; Li P; Sun W; Kong XQ
    J Zhejiang Univ Sci B; 2020 Jul; 21(7):509-523. PubMed ID: 32633106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
    Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
    J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer.
    Huang X; Guo H; Wang L; Yang L; Shao Z; Zhang W
    Mol Ther Nucleic Acids; 2022 Mar; 27():947-955. PubMed ID: 35211355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N
    Dorn LE; Lasman L; Chen J; Xu X; Hund TJ; Medvedovic M; Hanna JH; van Berlo JH; Accornero F
    Circulation; 2019 Jan; 139(4):533-545. PubMed ID: 30586742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
    Qi LW; Jia JH; Jiang CH; Hu JM
    Front Genet; 2020; 11():614566. PubMed ID: 33519919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N6-Methyladenosine RNA Methylation in Cardiovascular Diseases.
    Liu C; Gu L; Deng W; Meng Q; Li N; Dai G; Yu S; Fang H
    Front Cardiovasc Med; 2022; 9():887838. PubMed ID: 35571209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
    Xie W; Ma LL; Xu YQ; Wang BH; Li SM
    Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-Methyladenosine Modifications in Pulmonary Hypertension.
    Xia Y; Zhang Y; Huang J; Chen B; Jiang Y; Sun Z; Liu Y
    Pharmacology; 2023; 108(6):497-503. PubMed ID: 37742623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m6A Methylation in Cardiovascular Diseases: From Mechanisms to Therapeutic Potential.
    Li L; Xu N; Liu J; Chen Z; Liu X; Wang J
    Front Genet; 2022; 13():908976. PubMed ID: 35836571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of m6A modification in fibrotic diseases and its potential therapeutic effect.
    Ye W; Lv X; Gao S; Li Y; Luan J; Wang S
    Biochem Pharmacol; 2023 Dec; 218():115873. PubMed ID: 37884198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-Methyladenosine-Modification-Related Ophthalmic Diseases and Potential Therapeutic Strategies.
    Chen X; Xie Y; Liu Q; Luo X; Gao Y
    Front Biosci (Landmark Ed); 2022 Nov; 27(11):304. PubMed ID: 36472104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m6A RNA methylation regulators could contribute to the occurrence of chronic obstructive pulmonary disease.
    Huang X; Lv D; Yang X; Li M; Zhang H
    J Cell Mol Med; 2020 Nov; 24(21):12706-12715. PubMed ID: 32961012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m6A regulator-mediated RNA methylation modification patterns and immune microenvironment infiltration characterization in severe asthma.
    Sun D; Yang H; Fan L; Shen F; Wang Z
    J Cell Mol Med; 2021 Nov; 25(21):10236-10247. PubMed ID: 34647423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA N6-methyladenosine modification, spermatogenesis, and human male infertility.
    Cai Z; Niu Y; Li H
    Mol Hum Reprod; 2021 May; 27(6):. PubMed ID: 33749751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.